- Market Realist•35 minutes ago
In 3Q16, Johnson & Johnson’s (JNJ) Medical Device segment revenues came in at ~$6.2 billion, compared to $6.1 billion in 3Q15.
- Market Realist•3 hours ago
On October 18, Johnson & Johnson (JNJ) released its 3Q16 earnings. After the announcement, Johnson & Johnson’s share price fell ~2% from $118.50 on October 17.
- Market Realist•7 hours ago
Pharmaceuticals segment Johnson & Johnson’s (JNJ) Pharmaceuticals segment comprises the immunology, infectious disease, neuroscience, oncology, and cardiovascular and metabolics franchises. Immunology ...
Johnson & Johnson (JNJ)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||113.24 x 300|
|Ask||113.59 x 300|
|Day's Range||112.99 - 114.24|
|52wk Range||94.28 - 126.07|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||21.14|
|Avg Vol (3m)||6,083,352|
|Dividend & Yield||3.20 (2.70%)|